Add listing
    0
    Add listing

    Mabylon AG Verified listing

    • Swiss Biotech Association
      Member

    Mabylon is leading innovation in human-derived antibody therapeutics for severe allergies, inflammation, and neurological disorders. MY006, our first-in-class multi-specific antibody therapeutic for peanut allergy, is tackling the growing food allergy market.

    Location
    Canton
    Facts & figures
    • Type of organization
      Private company
    • Year of foundation
      2015
    • Number of employees in Switzerland
      20-49
    Key business

    You may also be interested in